Viz.ai
AI care coordination platform with 50+ FDA-cleared algorithms across neurology, cardiology, vascular, pulmonary, and trauma.
Viz.ai is the only platform with 50+ FDA-cleared algorithms spanning six therapeutic areas, backed by real-world clinical validation. Its enterprise-only focus and opaque pricing make it overkill for small clinics, but for large health systems aiming to cut door-to-treatment times, it's the clear leader.
Verified 18d ago · liveness 93/100 · cite: rightaichoice.com/tools/viz-ai
- Large hospitals and health systems seeking multi-departmental AI care coordination
- Stroke centers needing rapid LVO and hemorrhage detection with team alerts
- Cardiology and vascular departments wanting automated detection of PE, aortic disease, HCM
- Level I trauma centers requiring streamlined trauma workflow and AI triage
- Small clinics or standalone imaging centers needing a simple AI tool without care coordination
- Organizations with limited IT support for complex PACS/EMR integration
- Budget-conscious buyers wanting transparent, upfront pricing
We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.
- Honest verdict, not marketing
- Real pros & cons from real users
- Attributed quotes with receipts
3 free scans · no card needed
Skip Viz.ai if you need transparent upfront pricing or you run a small clinic without the IT infrastructure to integrate with PACS and EMR systems.
Enterprise contracts typically require annual commitments, so you can't pay month-to-month without a long-term agreement.
Viz.ai uses contact sales pricing tailored to enterprise health systems, typically costing hundreds of thousands per year. This positions it as a premium investment compared to standalone AI tools (e.g., Aidoc's individual algorithms) that may offer lower entry points. For large multi-hospital networks, the per-site license may be cost-effective given the coordination benefits; for smaller facilities, it's expensive versus simpler single-specialty AI.
In short
Viz.ai — AI care coordination platform with 50+ FDA-cleared algorithms across neurology, cardiology, vascular, pulmonary, and trauma. Best for Large hospitals and health systems seeking multi-departmental AI care coordination, Stroke centers needing rapid LVO and hemorrhage detection with team alerts, Cardiology and vascular departments wanting automated detection of PE, aortic disease, HCM. Contact Sales pricing.
What's new in Viz.ai
Checked 18 days agoAcross the latest 2 updates: 2 news mentions.
Unlocking the Potential of AI in Lung Disease Diagnosis
Discusses AI applications in lung cancer, interstitial lung disease, pulmonary hypertension, and bronchiectasis.
The Answer to the US Healthcare Crisis? AI Care Pathways
CEO and Chief Clinical Officer discuss how AI care pathways can reduce costs and improve outcomes across the system.
Viability Score
How likely is Viz.ai to still be operational in 12 months? Based on 4 signals — momentum (how recently it shipped), wrapper dependency, revenue model, and web presence.
Last calculated: July 2026
How we score →Key Features
- 50+ FDA-cleared AI algorithms
- Real-time mobile alerts for suspected diseases
- Automated LVO detection from CT scans
- CTP, hemorrhage, aneurysm, hyperdensity measurements
- Viz.ai One enterprise platform
- Viz Assist workflow assistant
- Viz Neuro Suite (stroke, aneurysm, CTP)
- Viz Cardio Suite (HCM, ACS, amyloidosis)
- Viz Vascular Suite (PE, aortic disease)
- Viz Pulmonary Suite (COPD, lung cancer detection)
- Viz Trauma Suite (trauma workflow)
- Viz Radiology Suite (radiology workflow)
- Integration with PACS, EMR, imaging systems
- Life sciences partnership for customized solutions
- 24/7 on-call clinical specialist support
About Viz.ai
Viz.ai is an enterprise AI-powered care coordination platform that analyzes medical imaging—including CT, EKG, and echocardiogram—in real time to detect suspected diseases across neurology, cardiology, vascular, pulmonary, trauma, and radiology. With over 50 FDA-cleared algorithms, it automates detection of conditions like large vessel occlusion (LVO), hemorrhage, aneurysm, pulmonary embolism, aortic disease, hypertrophic cardiomyopathy (HCM), and—since April 2026—pulmonary diseases via the new Viz Pulmonary Suite, which includes COPD and lung cancer detection. The platform includes Viz.ai One (enterprise), Viz Assist (workflow assistant), mobile and desktop alerts, and deep integrations with PACS, EMR, and Microsoft Cloud for Healthcare. Unlike siloed AI tools, Viz.ai unifies multi-specialty detection with care coordination, proven in peer-reviewed studies to reduce time to treatment. It also offers life sciences partnerships for clinical trial patient identification. Recent milestones include ISO/IEC 42001 certification for agentic AI governance and a partnership with NRHA to bring AI to rural hospitals. While its comprehensive scope and FDA-cleared algorithms are unmatched, the platform requires enterprise-level IT support and lacks transparent pricing.
Behind the Verdict
Viz.ai is the most comprehensive AI care coordination platform on the market, with 50+ FDA-cleared algorithms covering neurology, cardiology, vascular, pulmonary, trauma, and radiology. The recent launch of the Viz Pulmonary Suite (April 2026) adds COPD and lung cancer detection, making it even broader. The platform's strength lies in its ability to auto-detect diseases from imaging (CT, EKG, echo) and immediately alert the care team via mobile or desktop, slashing time to treatment. Real-world studies back this—Viz.ai has published data showing significant reductions in door-to-needle times for stroke and PE. We'd reach for Viz.ai when we need a unified AI layer across multiple departments, especially in large health systems or stroke centers. The recent NRHA partnership (April 2026) also signals it's working to serve rural hospitals, though implementation still requires IT support. ISO/IEC 42001 certification (May 2026) adds credibility for governance-conscious buyers. Where it bites: Viz.ai is not for you if you're a small clinic or standalone imaging center. It's an enterprise platform requiring deep integration with PACS, EMR, and existing workflows. Pricing is opaque—contact sales only—which frustrates budget-conscious buyers. Also, its focus is detection and coordination, not just image analysis; radiologists who only want AI reads may find the communication features extraneous. Compared to alternatives like Aidoc (also multi-modality, but narrower FDA clearance count) or RapidAI (stroke-focused), Viz.ai wins on breadth of FDA-cleared algorithms and care coordination features. However, those competitors sometimes offer more transparent pricing or lighter deployments. For life sciences partners, Viz.ai's customized solutions for clinical trial enrollment are a
Researching Viz.ai? Get your full AI stack in 60 seconds.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Real-world workflow fit
Concrete scenarios for the personas Viz.ai actually fits — and what changes day-one when you adopt it.
On-call at a comprehensive stroke center with multiple affiliated hospitals
Outcome: Receive a mobile alert within seconds of a CT scan being completed, showing LVO likelihood, enabling pre-arrival team activation and reducing door-to-needle time.
Implementing a system-wide AI coordination platform across 5 hospitals
Outcome: Deploy Viz.ai One with unified analytics dashboard, standardize stroke and PE workflows, and track outcomes across sites with peer-reviewed benchmarks.
Identifying eligible patients for a new pulmonary drug trial
Outcome: Use Viz Pulmonary Suite's AI detection to flag patients with COPD or lung cancer on chest CTs, automatically populate trial screening lists, and accelerate enrollment.
Use Cases
- Automated LVO detection from CT scans with real-time stroke team alerting
- Multi-condition screening on a single chest CT (PE, aortic disease, coronary calcium)
- Health system-wide deployment with unified analytics dashboard across hospitals
- AI-powered patient identification for life sciences clinical trials
- Rapid detection and triage of pulmonary embolism via Viz Pulmonary Suite
- Trauma center workflow automation with AI triage
- Radiology workflow optimization with automated measurements and alerts
Models Under the Hood
as of 2026-07-14
Limitations
- Custom pricing may be prohibitive for smaller facilities.
- Requires integration with existing hospital IT systems (PACS, EHR).
- Current AI models cover only specific conditions (stroke, PE, aortic disease, cardiac, pulmonary, oncology, trauma).
- No patient-facing features.
- Ongoing algorithm updates create vendor dependency.
as of 2026-06-30
Where the pricing makes sense
The company stage and team size where Viz.ai's pricing actually pencils out — and where peers do it cheaper.
Viz.ai uses contact sales pricing tailored to enterprise health systems, typically costing hundreds of thousands per year. This positions it as a premium investment compared to standalone AI tools (e.g., Aidoc's individual algorithms) that may offer lower entry points. For large multi-hospital networks, the per-site license may be cost-effective given the coordination benefits; for smaller facilities, it's expensive versus simpler single-specialty AI.
Setup time & first value
How long it actually takes to get something useful out of Viz.ai — broken out by persona, not the marketing-page minute.
For large health systems, initial setup and PACS/EMR integration typically takes 4–8 weeks, including IT configuration and staff training. Stroke centers can often see first alerts within 2 weeks of PACS integration. Viz Assist workflow customization adds 1–2 weeks. Remote sites in rural partnerships (e.g., NRHA initiative) may have accelerated timelines with Viz.ai's support team.
Switching to or from Viz.ai
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
- →From (manual stroke triage): Replace pager-based call chains with Viz.ai's automated mobile alerts and image sharing
- →From (single-specialty AI tool like Aidoc): Expand to multi-specialty by adopting Viz.ai's unified platform covering neuro, cardio, vascular, and pulmonary
- ↗To (alternative enterprise AI platform like Aidoc or RapidAI): Export integration configurations and workflow rules; retrain staff on new platform
- ↗To (in-house custom solution): Extract algorithm outputs and alert logs for custom pipeline; may require maintaining PACS connectors
Integrations
Resources & Guides
- Resourceviz.ai
Support · Viz.ai
Helpful link from viz.ai
- Resourceviz.ai
Resources · Viz.ai
Helpful link from viz.ai
- Resourceviz.ai
Webinars · Viz.ai
Helpful link from viz.ai
- Resourceviz.ai
Case Studies · Viz.ai
Helpful link from viz.ai
- Resourceviz.ai
Clinical Validation · Viz.ai
Helpful link from viz.ai
- Resourceviz.ai
Blog · Viz.ai
Helpful link from viz.ai
- Resourceviz.ai
White Papers · Viz.ai
Helpful link from viz.ai
Official links
Tools that pair well with Viz.ai
Common stack mates teams adopt alongside Viz.ai, with the specific reason each pairing earns its keep.
Alternatives to Viz.ai
View allFrequently Asked Questions
Categories
Best-of guides
Topics
Used Viz.ai? Help shape our editorial sentiment research.